Ocugen, Inc. financial data

Symbol
OCGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Great Valley Parkway, Malvern, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
HISTOGENICS CORP (to 9/26/2019)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 262 % -38%
Debt-to-equity 55.7 % +53.3%
Return On Equity -128 % -24.7%
Return On Assets -82.4 % -9.21%
Operating Margin -904 % +75.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 257M shares +13.6%
Common Stock, Shares, Outstanding 257M shares +13.6%
Entity Public Float 137M USD -71.6%
Common Stock, Value, Issued 2.58M USD +13.7%
Weighted Average Number of Shares Outstanding, Basic 257M shares +14.1%
Weighted Average Number of Shares Outstanding, Diluted 257M shares +14.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.61M USD +172%
General and Administrative Expense 30.1M USD -10.4%
Operating Income (Loss) -59.7M USD +32.2%
Nonoperating Income (Expense) 2.04M USD -31.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63.1M USD +27.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -57.7M USD +32.2%
Earnings Per Share, Basic -0.23 USD/shares +41%
Earnings Per Share, Diluted -0.23 USD/shares +41%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.4M USD -61.4%
Assets, Current 30M USD -64.5%
Property, Plant and Equipment, Net 17.7M USD +122%
Operating Lease, Right-of-Use Asset 3.94M USD +0.87%
Other Assets, Noncurrent 4.14M USD +4.97%
Assets 51.8M USD -46.2%
Accounts Payable, Current 1.73M USD -78.6%
Employee-related Liabilities, Current 882K USD -44.6%
Accrued Liabilities, Current 9.9M USD +129%
Liabilities, Current 16.1M USD -39.6%
Operating Lease, Liability, Noncurrent 3.41M USD -1.02%
Other Liabilities, Noncurrent 536K USD +73.5%
Liabilities 21.5M USD -31.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 25K USD 0%
Retained Earnings (Accumulated Deficit) -298M USD -24%
Stockholders' Equity Attributable to Parent 30.3M USD -53.4%
Liabilities and Equity 51.8M USD -46.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +41.9%
Net Cash Provided by (Used in) Financing Activities -145K USD -103%
Net Cash Provided by (Used in) Investing Activities -2.35M USD -168%
Common Stock, Shares Authorized 295M shares 0%
Common Stock, Shares, Issued 257M shares +13.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.1M USD -40.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.4M USD -61.4%
Deferred Tax Assets, Valuation Allowance 112M USD +17.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 113M USD +17.2%
Operating Lease, Liability 4M USD +1.06%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +45.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57.7M USD +32.2%
Lessee, Operating Lease, Liability, to be Paid 5.67M USD +17.7%
Property, Plant and Equipment, Gross 19.1M USD +118%
Operating Lease, Liability, Current 589K USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 834K USD +2.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 810K USD +2.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +46.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.67M USD +94.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 858K USD +2.88%
Deferred Tax Assets, Operating Loss Carryforwards 58.3M USD +19.5%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 303K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 884K USD +6%
Additional Paid in Capital 326M USD +7.5%
Depreciation, Depletion and Amortization 480K USD +110%
Deferred Tax Assets, Net of Valuation Allowance 918K USD -5.85%
Share-based Payment Arrangement, Expense 8.29M USD -16.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%